Parkin-mediated K63-linked polyubiquitination: a signal for targeting misfolded proteins to the aggresome-autophagy pathway - PubMed (original) (raw)
Parkin-mediated K63-linked polyubiquitination: a signal for targeting misfolded proteins to the aggresome-autophagy pathway
James A Olzmann et al. Autophagy. 2008 Jan.
Abstract
Pathological inclusions containing misfolded proteins are a prominent feature common to many age-related neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis. In cultured cells, when the production of misfolded proteins exceeds the capacity of the chaperone refolding system and the ubiquitin-proteasome degradation pathway, misfolded proteins are actively transported along microtubules to pericentriolar inclusions called aggresomes. The aggresomes sequester potentially toxic misfolded proteins and facilitate their clearance by autophagy. The molecular mechanism(s) that targets misfolded proteins to the aggresome-autophagy pathway is mostly unknown. Our recent work identifies parkin-mediated K63-linked polyubiquitination as a signal that couples misfolded proteins to the dynein motor complex via the adaptor protein histone deacetylase 6 and thereby promotes sequestration of misfolded proteins into aggresomes and subsequent clearance by autophagy. Our findings provide insight into the mechanisms underlying aggresome formation and suggest that parkin and K63-linked polyubiquitination may play a role in the autophagic clearance of misfolded proteins.
Figures
Figure 1
A model of parkin function in the clearance of misfolded proteins by the aggresome-autophagy pathway. Under conditions of proteasomal impairment, parkin coordinates the E2 enzyme UbcH13/Uev1a to mediate K63-linked polyubiquitination of misfolded proteins (step 1). This K63-linked polyubiquitin chain promotes binding to HDAC6 (step 2) and thereby links the ubiquitinated proteins to the dynein motor complex for transport to the aggresome (step 3). Autophagic membrane and machinery are recruited to the aggresome (step 4). The autophagosome then fuses with lysosomes to form an autophagolysosome and thus allows the degradation of misfolded and aggregated proteins by lysosomal hydrolases (step 5).
Similar articles
- Parkin-mediated ubiquitin signalling in aggresome formation and autophagy.
Chin LS, Olzmann JA, Li L. Chin LS, et al. Biochem Soc Trans. 2010 Feb;38(Pt 1):144-9. doi: 10.1042/BST0380144. Biochem Soc Trans. 2010. PMID: 20074049 Free PMC article. Review. - Aggresome formation and neurodegenerative diseases: therapeutic implications.
Olzmann JA, Li L, Chin LS. Olzmann JA, et al. Curr Med Chem. 2008;15(1):47-60. doi: 10.2174/092986708783330692. Curr Med Chem. 2008. PMID: 18220762 Free PMC article. Review. - Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6.
Olzmann JA, Li L, Chudaev MV, Chen J, Perez FA, Palmiter RD, Chin LS. Olzmann JA, et al. J Cell Biol. 2007 Sep 10;178(6):1025-38. doi: 10.1083/jcb.200611128. J Cell Biol. 2007. PMID: 17846173 Free PMC article. - Parkin Protects Against Misfolded SOD1 Toxicity by Promoting Its Aggresome Formation and Autophagic Clearance.
Yung C, Sha D, Li L, Chin LS. Yung C, et al. Mol Neurobiol. 2016 Nov;53(9):6270-6287. doi: 10.1007/s12035-015-9537-z. Epub 2015 Nov 13. Mol Neurobiol. 2016. PMID: 26563499 Free PMC article. - E3 ligase Smurf1 protects against misfolded SOD1 in neuronal cells by promoting its K63 ubiquitylation and aggresome formation.
Dong L, Liu L, Li Y, Li W, Zhou L, Xia Q. Dong L, et al. Hum Mol Genet. 2022 Jun 22;31(12):2035-2048. doi: 10.1093/hmg/ddac008. Hum Mol Genet. 2022. PMID: 35022748
Cited by
- Cytosolic chaperones mediate quality control of higher-order septin assembly in budding yeast.
Johnson CR, Weems AD, Brewer JM, Thorner J, McMurray MA. Johnson CR, et al. Mol Biol Cell. 2015 Apr 1;26(7):1323-44. doi: 10.1091/mbc.E14-11-1531. Epub 2015 Feb 11. Mol Biol Cell. 2015. PMID: 25673805 Free PMC article. - Mitochondrial dysfunction precedes other sub-cellular abnormalities in an in vitro model linked with cell death in Parkinson's disease.
Yong-Kee CJ, Sidorova E, Hanif A, Perera G, Nash JE. Yong-Kee CJ, et al. Neurotox Res. 2012 Feb;21(2):185-94. doi: 10.1007/s12640-011-9259-6. Epub 2011 Jul 20. Neurotox Res. 2012. PMID: 21773851 - Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss.
Lee Y, Karuppagounder SS, Shin JH, Lee YI, Ko HS, Swing D, Jiang H, Kang SU, Lee BD, Kang HC, Kim D, Tessarollo L, Dawson VL, Dawson TM. Lee Y, et al. Nat Neurosci. 2013 Oct;16(10):1392-400. doi: 10.1038/nn.3500. Epub 2013 Aug 25. Nat Neurosci. 2013. PMID: 23974709 Free PMC article. - UCH-L1 Inhibition Suppresses tau Aggresome Formation during Proteasomal Impairment.
Yu Q, Zhang H, Li Y, Liu C, Wang S, Liao X. Yu Q, et al. Mol Neurobiol. 2018 May;55(5):3812-3821. doi: 10.1007/s12035-017-0558-7. Epub 2017 May 24. Mol Neurobiol. 2018. PMID: 28540657 - ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3.
Hernández-Carralero E, Quinet G, Freire R. Hernández-Carralero E, et al. Expert Rev Mol Med. 2024 Sep 25;26:e19. doi: 10.1017/erm.2024.10. Expert Rev Mol Med. 2024. PMID: 39320846 Free PMC article. Review.
References
- Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;10(Suppl):S10–7. - PubMed
- Garcia-Mata R, Gao YS, Sztul E. Hassles with taking out the garbage: aggravating aggresomes. Traffic. 2002;3:388–96. - PubMed
- Kopito RR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000;10:524–30. - PubMed
- Kristiansen M, Deriziotis P, Dimcheff DE, Jackson GS, Ovaa H, Naumann H, Clarke AR, van Leeuwen FW, Menendez-Benito V, Dantuma NP, Portis JL, Collinge J, Tabrizi SJ. Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell. 2007;26:175–88. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- F31 NS054597-02/NS/NINDS NIH HHS/United States
- NS050650/NS/NINDS NIH HHS/United States
- F31 NS054597-01/NS/NINDS NIH HHS/United States
- F31 NS054597/NS/NINDS NIH HHS/United States
- NS054597/NS/NINDS NIH HHS/United States
- R01 NS050650-03/NS/NINDS NIH HHS/United States
- R01 NS050650-01A1/NS/NINDS NIH HHS/United States
- R01 NS050650/NS/NINDS NIH HHS/United States
- R01 NS050650-02/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources